We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Decision on Alexion’s Kanuma Pushed Back Three Months
FDA Decision on Alexion’s Kanuma Pushed Back Three Months
The FDA has delayed by three months its decision on Alexion Pharmaceuticals‘s metabolic disorder drug Kanuma to review new chemical manufacturing and controls information.